Lemdani et al. [44] combined RFA with a GM-CSF-BCG hydrogel, which induced primary tumor regression in a murine colorectal carcinoma model, and completely eradicated microscopic secondary lesions. The gene discussed is CSF2; the disease is neoplasm.